2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular diseaseAntonio Pelliccia, Steffen E Petersen, Jonathan Myers et al.|European Heart Journal|2020Cited by 1.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Mavacamten in Symptomatic Nonobstructive Hypertrophic CardiomyopathyMilind Y. Desai, Steven E. Nissen, Anjali Owens et al.|New England Journal of Medicine|2025Cited by 51
Improved percent-predicted peak VO2 is associated with lower risk of hospitalization in patients with coronary heart disease. Analysis from the FRIEND registryGiorgio Chiaranda, Giovanni Grazzi, Jonathan Myers et al.|International Journal of Cardiology|2020Cited by 17
Impact of Improvement in Walking Speed on Hospitalization and Mortality in Females with Cardiovascular DiseaseGiovanni Grazzi, Giorgio Chiaranda, Gianni Mazzoni et al.|Journal of Clinical Medicine|2020Cited by 12